SAN DIEGO, Nov. 5, 2010 /PRNewswire-FirstCall/ — Sequenom, Inc.
(Nasdaq:
SQNM) today announced that company management will present an
overview of the company at the following conferences in
November.
(Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO)
(Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO)
- Lazard Capital Markets 7th Annual Healthcare Conference
- Location: The St. Regis, New York, NY
- Presentation date: Tuesday November 16, 2010
- Presentation time: 11:25am ET
- Presenter: Harry F. Hixson Jr PhD, Chairman and CEO
- Stephens Fall Investment Conference
- Location: The Palace Hotel, New York, NY
- Presentation date: Wednesday November 17, 2010
- Presentation time: 1:00pm ET
- Presenter: Harry F. Hixson Jr PhD, Chairman and CEO
A live webcast and 30-day archive of these presentations will be
available at http://ir.sequenom.com.
About Sequenom
Sequenom, Inc. (NASDAQ:
SQNM) is a life sciences company committed to improving
healthcare through revolutionary genetic analysis solutions.
Sequenom develops innovative technology, products and diagnostic
tests that target and serve discovery and clinical research, and
molecular diagnostics markets. The company was founded in 1994 and
is headquartered in San Diego, California. Sequenom maintains a
website at http://www.sequenom.com to
whi
‘/>”/>
SOURCE
